Literature DB >> 23760446

Transcriptional profiling of HMGB1-induced myocardial repair identifies a key role for Notch signaling.

Federica Limana1, Grazia Esposito, Pasquale Fasanaro, Eleonora Foglio, Diego Arcelli, Christine Voellenkle, Anna Di Carlo, Daniele Avitabile, Fabio Martelli, Matteo Antonio Russo, Giulio Pompilio, Antonia Germani, Maurizio C Capogrossi.   

Abstract

Exogenous high-mobility group box 1 protein (HMGB1) administration to the mouse heart, during acute myocardial infarction (MI), results in cardiac regeneration via resident c-kit(+) cell (CPC) activation. Aim of the present study was to identify the molecular pathways involved in HMGB1-induced heart repair. Gene expression profiling was performed to identify differentially expressed genes in the infarcted and bordering regions of untreated and HMGB1-treated mouse hearts, 3 days after MI. Functional categorization of the transcripts, accomplished using Ingenuity Pathway Analysis software (IPA), revealed that genes involved in tissue regeneration, that is, cardiogenesis, vasculogenesis and angiogenesis, were present both in the infarcted area and in the peri-infarct zone; HMGB1 treatment further increased the expression of these genes. IPA revealed the involvement of Notch signaling pathways in HMGB1-treated hearts. Importantly, HMGB1 determined a 35 and 58% increase in cardiomyocytes and CPCs expressing Notch intracellular cytoplasmic domain, respectively. Further, Notch inhibition by systemic treatment with the γ-secretase inhibitor DAPT, which blocked the proteolytic activation of Notch receptors, reduced the number of CPCs, their proliferative fraction, and cardiomyogenic differentiation in HMGB1-treated infarcted hearts. The present study gives insight into the molecular processes involved in HMGB1-mediated cardiac regeneration and indicates Notch signaling as a key player.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23760446      PMCID: PMC3808142          DOI: 10.1038/mt.2013.137

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


  51 in total

1.  Altered patterns of gene expression in response to myocardial infarction.

Authors:  L W Stanton; L J Garrard; D Damm; B L Garrick; A Lam; A M Kapoun; Q Zheng; A A Protter; G F Schreiner; R T White
Journal:  Circ Res       Date:  2000-05-12       Impact factor: 17.367

2.  A gamma-secretase inhibitor blocks Notch signaling in vivo and causes a severe neurogenic phenotype in zebrafish.

Authors:  Andrea Geling; Harald Steiner; Michael Willem; Laure Bally-Cuif; Christian Haass
Journal:  EMBO Rep       Date:  2002-07       Impact factor: 8.807

3.  Nerve growth factor promotes cardiac repair following myocardial infarction.

Authors:  Marco Meloni; Andrea Caporali; Gallia Graiani; Costanza Lagrasta; Rajesh Katare; Sophie Van Linthout; Frank Spillmann; Ilaria Campesi; Paolo Madeddu; Federico Quaini; Costanza Emanueli
Journal:  Circ Res       Date:  2010-04-01       Impact factor: 17.367

4.  Hypoxia requires notch signaling to maintain the undifferentiated cell state.

Authors:  Maria V Gustafsson; Xiaowei Zheng; Teresa Pereira; Katarina Gradin; Shaobo Jin; Johan Lundkvist; Jorge L Ruas; Lorenz Poellinger; Urban Lendahl; Maria Bondesson
Journal:  Dev Cell       Date:  2005-11       Impact factor: 12.270

5.  Molecular dynamics of the compensatory response to myocardial infarct.

Authors:  W A LaFramboise; K L Bombach; R J Dhir; N Muha; R F Cullen; A R Pogozelski; D Turk; J D George; R D Guthrie; J A Magovern
Journal:  J Mol Cell Cardiol       Date:  2004-12-08       Impact factor: 5.000

6.  Sphingolipid signaling and treatment during remodeling of the uninfarcted ventricular wall after myocardial infarction.

Authors:  Che-Chung Yeh; Hongzhe Li; Deepak Malhotra; Mei-Chuan Huang; Bo-Qing Zhu; Edward J Goetzl; Donald A Vessey; Joel S Karliner; Michael J Mann
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-02-20       Impact factor: 4.733

7.  Activation of Notch-mediated protective signaling in the myocardium.

Authors:  Natalie A Gude; Gregory Emmanuel; Weitao Wu; Christopher T Cottage; Kimberlee Fischer; Pearl Quijada; John A Muraski; Roberto Alvarez; Marta Rubio; Eric Schaefer; Mark A Sussman
Journal:  Circ Res       Date:  2008-03-27       Impact factor: 17.367

8.  The homeodomain protein Cux1 interacts with Grg4 to repress p27 kip1 expression during kidney development.

Authors:  Madhulika Sharma; Jennifer G Brantley; Dianne Vassmer; Gaurav Chaturvedi; Jennifer Baas; Gregory B Vanden Heuvel
Journal:  Gene       Date:  2009-03-28       Impact factor: 3.688

9.  High-mobility group box 1 restores cardiac function after myocardial infarction in transgenic mice.

Authors:  Tatsuro Kitahara; Yasuchika Takeishi; Mutsuo Harada; Takeshi Niizeki; Satoshi Suzuki; Toshiki Sasaki; Mitsunori Ishino; Olga Bilim; Osamu Nakajima; Isao Kubota
Journal:  Cardiovasc Res       Date:  2008-06-16       Impact factor: 10.787

10.  Noncanonical Wnt11 signaling is sufficient to induce cardiomyogenic differentiation in unfractionated bone marrow mononuclear cells.

Authors:  Michael P Flaherty; Ahmed Abdel-Latif; Qianhong Li; Greg Hunt; Smita Ranjan; Qinghu Ou; Xian-Liang Tang; Robin K Johnson; Roberto Bolli; Buddhadeb Dawn
Journal:  Circulation       Date:  2008-04-21       Impact factor: 29.690

View more
  11 in total

1.  High-mobility group box 1: a novel target for treatment of Pseudomonas aeruginosa keratitis.

Authors:  Sharon McClellan; Xiaoyu Jiang; Ronald Barrett; Linda D Hazlett
Journal:  J Immunol       Date:  2015-01-14       Impact factor: 5.422

Review 2.  c-kit(+) cells: the tell-tale heart of cardiac regeneration?

Authors:  Patrizia Nigro; Gianluca Lorenzo Perrucci; Aoife Gowran; Marco Zanobini; Maurizio C Capogrossi; Giulio Pompilio
Journal:  Cell Mol Life Sci       Date:  2015-01-10       Impact factor: 9.261

Review 3.  HMGB1 in health and disease.

Authors:  Rui Kang; Ruochan Chen; Qiuhong Zhang; Wen Hou; Sha Wu; Lizhi Cao; Jin Huang; Yan Yu; Xue-Gong Fan; Zhengwen Yan; Xiaofang Sun; Haichao Wang; Qingde Wang; Allan Tsung; Timothy R Billiar; Herbert J Zeh; Michael T Lotze; Daolin Tang
Journal:  Mol Aspects Med       Date:  2014-07-08

Review 4.  Signaling pathways and targeted therapy for myocardial infarction.

Authors:  Qing Zhang; Lu Wang; Shiqi Wang; Hongxin Cheng; Lin Xu; Gaiqin Pei; Yang Wang; Chenying Fu; Yangfu Jiang; Chengqi He; Quan Wei
Journal:  Signal Transduct Target Ther       Date:  2022-03-10

Review 5.  The role of notch in the cardiovascular system: potential adverse effects of investigational notch inhibitors.

Authors:  Paola Rizzo; Donato Mele; Cristiana Caliceti; Micaela Pannella; Cinzia Fortini; Anthony George Clementz; Marco Bruno Morelli; Giorgio Aquila; Pietro Ameri; Roberto Ferrari
Journal:  Front Oncol       Date:  2015-01-13       Impact factor: 6.244

6.  High mobility group box 1 protein attenuates myocardial ischemia reperfusion injury via inhibition of the p38 mitogen-activated protein kinase signaling pathway.

Authors:  Yan-Hong Zhou; Qian-Feng Han; Lan-Hua Wang; Tao Liu; Xiao-Yan Meng; Lei Wu; Tai Li; Yue-Ru Jiao; Heng-Chen Yao; De-Yong Zhang
Journal:  Exp Ther Med       Date:  2017-06-22       Impact factor: 2.447

Review 7.  Notch Signaling in Ischemic Damage and Fibrosis: Evidence and Clues from the Heart.

Authors:  Silvia Nistri; Chiara Sassoli; Daniele Bani
Journal:  Front Pharmacol       Date:  2017-04-05       Impact factor: 5.810

Review 8.  DAMPs from Cell Death to New Life.

Authors:  Emilie Vénéreau; Chiara Ceriotti; Marco Emilio Bianchi
Journal:  Front Immunol       Date:  2015-08-18       Impact factor: 7.561

9.  rhHMGB1 drives osteoblast migration in a TLR2/TLR4- and NF-κB-dependent manner.

Authors:  Ming-Jing Li; Fan Li; Jian Xu; Yu-Dong Liu; Tao Hu; Jian-Ting Chen
Journal:  Biosci Rep       Date:  2016-01-07       Impact factor: 3.840

10.  Biomarkers identification for acute myocardial infarction detection via weighted gene co-expression network analysis.

Authors:  Shu Zhang; Weixia Liu; Xiaoyan Liu; Jiaxin Qi; Chunmei Deng
Journal:  Medicine (Baltimore)       Date:  2017-11       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.